• Home
  • Sepsis
  • Technology
  • Patents
  • Investors
  • About
  • Contact
  • Home
  • Sepsis
  • Technology
  • Patents
  • Investors
  • About
  • Contact
GUANINE INC.
  • Home
  • Sepsis
  • Technology
  • Patents
  • Investors
  • About
  • Contact
About


BACKGROUND

Guanine's platform evolved from the convergence of nanotech, biotech, and infotech

Guanine's founder Neil Gordon was one the first business consultants in the nanotechnology sector and worked with many of the nanotechnology pioneers through his boutique consulting practice, the NanoBusiness Alliance, and the NASA-led CANEUS consortium for micro and nano technologies in the aerospace and industries.

Guanine’s predecessor company was spun out of NASA’s Ames Research Center and adapted NASA’s carbon nanotube sensor to detect guanine oxidation signals from bacterial and viral RNA. Neil and his team re-engineered the NASA sensor and produced guanine oxidation from synthetic DNA comprising guanine nucleotides.

When a string of nucleotides was fabricated into a quadruplex by coiling guanine molecules around sodium cations the structure produced a stronger electrical signal from 8-oxoguanine that detected lower concentrations of targets. Guanine had integrated the electronic sensor signals with artificial intelligence tools to diagnose infections from test results and symptoms.


Picture

MANAGEMENT


Picture
Neil Gordon B.Eng, MBA
President & CEO  email  LinkedIn

Neil is a business executive specializing in managing advanced technology products and ventures. He was one of the one of first business consultants in nanotechnology. He headed commercialization for the NASA-led CANEUS and spun out a company from NASA’s Ames Research Center to commercialize NASA’s carbon nanotube sensor. He co-developed a testing instrument for detecting RNA from bacteria and viruses. He subsequently invented and patented  the quadruplex detection tag, the electronic sensor, and AI diagnosis platform.    


Picture
Garry Palmateer M.Sc.
Vice President, Assays 

Garry is a microbiologist with over 40 years experience in detecting bacteria and viruses. Garry previously operated pathogen testing labs in the private sector and for the Ontario Government. He oversaw remediation of the Walkerton E.coli outbreak. Garry co-developed the pathogen sensor and inline testing instrument at Guanine's predecessor NASA spin-off company. He developed assay protocols for various pathogens including a rapid test for carbapenem resistance using the electronic sensor.


Picture
Raj Bawa MD, PhD
VP and Chief IP Officer
 
Raj is a MD PhD with background as a microbiologist and a pioneer in nanomedicine. He has been an active researcher for over three decades and has extensive hands-on bench experience, patent law track record and commercialization expertise. Raj is leading Guanine’s efforts to apply the technology to early stage sepsis diagnosis.


Picture
Ara Altounian B.Eng, MBA
Vice President, Operations
 
Ara is an engineer/MBA with diverse experience in engineering, retail, software design and instruments. His career spans many aspects of management, operations, and administration.


Picture

Copyright 2022 © Guanine Inc. All rights reserved.